Array BioPharma - 48 Year Dividend History | ARRY

Historical dividend payout and yield for Array BioPharma (ARRY) since 1971. The current TTM dividend payout for Array BioPharma (ARRY) as of July 19, 2019 is $0.00. The current dividend yield for Array BioPharma as of July 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.373B $0.174B
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company's proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $82.919B 10.07
CSL (CSLLY) Australia $35.794B 0.00
Bio-Techne Corp (TECH) United States $7.933B 54.13